Skip Navigation

Cardio NewsWire


Please click here to view the archive of previous Cardio NewsWire stories. Each item is removed from the archive after 90 days.

Aortic stenosis patients 1 year after intervention
Russian National Congress of Cardiology
New ACCA Research Prize in 2014
Gender specific testing for IHD


A survey, published online in the European Journal of Cardio-Thoracic Surgery, of 13,860 patients who had undergone interventions for aortic valve disease in Germany has revealed that over 80% were in the same or a better state of health one year after the intervention, and were satisfied with the procedural outcome.

Prof. Friedrich-Wilhelm Mohr and colleagues used the German Aortic Valve Registry (GARY) to look at the 13,860 registered patients undergoing either AVR or TAVR procedures from 2011. Enrolment in the Registry was voluntary, and took place in 78 German centres. Baseline, procedural, and outcome data, including quality of life, were acquired up to one year post-intervention. Vital status at one year was known for just over 98% of patients.

One-year mortality was 6.7% (6,523) for conventional AVR patients and 11% (3,464) for patients who underwent AVR with CABG. One-year mortality 20.7% and 28% in transvascular TAVR and transapical TAVR procedures respectively. However, if patients were stratified into four risk groups, the highest-risk cohorts showed the same mortality at one year regardless of type of therapy.

Prof. Mohr said: “GARY is unique in that it includes all interventional and surgical treatment options for aortic valve disease that are currently available in Germany. Our aim was to obtain a comprehensive and contemporary picture of the current practice of aortic valve intervention therapy and to create an independent database that will allow for long-term follow-up of those patients.”

“The one-year results of the German Aortic Valve Registry confirm in a large ‘real world’, all-comer patient population that conventional surgery in operable patients’ yields excellent results in all risk groups. TAVR is being performed in a significant proportion of cases and is a good alternative for high-risk patients. Continuation of the registry and long-term follow-up will help to develop robust future risk models to predict patient outcomes for each treatment option in patients with aortic stenosis.”

Source: European Journal of Cardio-Thoracic Surgery


The Russian National Congress of Cardiology will take place in Kazan, 24-26 September, 2014.

The Congress scientific programme will include the most prominent modern achievements in prevention, diagnostics and treatment of cardiovascular diseases. An interdisciplinary approach to the problems is of exceptional value, as it fully represents the current trend to integrate knowledge in medical science. No less important is a strong educational component of plenary sessions, symposia, clinical discussions, scientific seminars, round tables, and master classes.

It is not by chance that the Congress will be held in Kazan where its famous scientific and clinical school contributed much to the reduction of cardiovascular morbidity and mortality in Russia. The capital of the Republic of Tatarstan will warmly welcome the Congress participants. The guests will come to know the thousand years of Tartar history and outstanding cultural values of one of the most beautiful Russian cities.

Main Topics:

• Improvement in Cardiology Care
• Fundamental Research
• New Medical Technologies
• Pharmacotherapy of Cardiovascular Diseases
• Congenital Cardiovascular Disorders
• Pulmonary Circulation Disorders
• Diabetes Mellitus and Cardiovascular Diseases
• Comorbidity in Cardiology
• Cardiac Problems in Perinatology and Paediatrics • Interventional Cardiology
• Surgical Methods in Cardiology
• Heart Transplantation
• Cardiac Rehabilitation
• Prevention of Cardiovascular Diseases
• Nursery Care Organization

The scientific program includes keynote lectures, plenary sessions, scientific symposiums, workshops, poster sessions, a Young Cardiologist Award session, as well as training sessions for practicing doctors.

During the Congress, the Russian Society of Cardiology Prize awarding ceremony will take place.

The final scientific program will be available at: 2 months prior to the event.


The Acute Cardiovascular Care Association is offering all scientists and clinicians the opportunity to gain recognition and win the new ACCA Research Prize in Acute Cardiovascular Care. The winner will receive a 3 000 Euro prize, in addition to other benefits and three runners up will also be rewarded. Find out more & apply

Acute Cardiovascular Care 2014 takes place 18-20 October 2014 in Geneva, Switzerland.


The American Heart Association (AHA) has published a statement on diagnostic testing for suspected ischaemic heart disease (IHD) in symptomatic women. The statement focuses on identifying non-obstructive and obstructive coronary artery disease (CAD).

Sex specific data are provided on the diagnostic and prognostic accuracy of numerous tests including exercise treadmill, ECG, stress echocardiography and stress cardiac MRI.

Gaps in knowledge about the assessment of IHD risk in women are identified.

The statement says that women are more likely than men to be diagnosed with non-obstructive coronary heart disease. Women previously diagnosed as having false positive stress tests may have non-obstructive coronary disease, placing them at risk for myocardial infarction. The statement is intended for women who have the symptoms of IHD, including the classic symptoms of left sided chest pain/pressure, jaw pain, upper back pain, widespread “indigestion,” and other symptoms not localised to the chest.

Recommendations include:

• Women with suspected IHD should discuss the benefits and risks of diagnostic tests with their healthcare provider – for example, a woman of child-bearing age may want to avoid tests that require exposure to radiation
• Healthcare professionals should consider whether a woman is at low, intermediate, or high risk for IHD when choosing the appropriate diagnostic tests
• Health care professionals, for the first time, should consider a woman’s functional ability to determine the type of diagnostic testing needed
• Women with the lowest risk should not undergo diagnostic testing; women at slightly higher risk should first undergo a treadmill exercise ECG; and symptomatic women with warning signs, including functional disability, might be candidates for cardiac MRI or cardiac CT angiography.

The document was published online on 16 June 2014